A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.

The symptoms of pancreatic cancer can be nonspecific, which means identifying the disease is often a challenge.

The problem with pancreatic cancer is that we often catch it too late,” he stated. The PAC-MANN test aims to enable ...

The results were impressive. PAC-MANN correctly identified pancreatic cancer in 98% of cases and was able to detect ...

Most of these lesions are benign or slow growing and the prognosis is significantly better than with pancreatic adenocarcinoma. However, some of these neoplasms slowly undergo malignant transformation ...

The lesion in the pancreatic tail was found to be benign, whereas the cytology of head lesion was reported as suspicious on first FNA and confirmed as adenocarcinoma on second FNA. Minor ...

The Mayo research team found that the combination of cytology and FISH raised the detection rate of bile duct and pancreatic cancer from 20 percent to 43 percent. "Bile duct and pancreatic cancers ...

The majority of breast, colorectal, kidney, liver, lung, oral, pancreatic, and prostate cancers are carcinomas. There are also variations in carcinoma cell types—such as adenosquamous carcinomas ...